Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent median survival rate (treated/control) at 300 mg...

Basic Information

ID: ALA704626

Type: Functional

Description: Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent median survival rate (treated/control) at 300 mg/kg (1 qd treatment schedule) dosage; 21.0/7.0

Format: BAO_0000218

Organism: Mus musculus

Cell type: L1210

Target:  L1210(ALA386)

Document:  ALA1123247

Antitumor activity was determined against the ic implanted L1210 lymphoid leukemia in mice by percent median survival rate (treated/control) at 300 mg/kg (1 qd treatment schedule) dosage; 21.0/7.0: 1

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
954.099.119.11